Cargando…
Epigenetic Regulation of Endothelial Dysfunction and Inflammation in Pulmonary Arterial Hypertension
Once perceived as a disorder treated by vasodilation, pulmonary artery hypertension (PAH) has emerged as a pulmonary vascular disease with severe endothelial cell dysfunction. In the absence of a cure, many studies seek to understand the detailed mechanisms of EC regulation to potentially create mor...
Autores principales: | Hudson, Jaylen, Farkas, Laszlo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8617605/ https://www.ncbi.nlm.nih.gov/pubmed/34829978 http://dx.doi.org/10.3390/ijms222212098 |
Ejemplares similares
-
Non-Invasive Assessment of Endothelial Dysfunction in Pulmonary Arterial Hypertension
por: Dara, Athanasia, et al.
Publicado: (2021) -
Endothelial cells are a source of Nestin expression in Pulmonary Arterial Hypertension
por: Bhagwani, Aneel R., et al.
Publicado: (2019) -
Role of Ion Channel Remodeling in Endothelial Dysfunction Induced by Pulmonary Arterial Hypertension
por: Santos-Gomes, Joana, et al.
Publicado: (2022) -
Endothelial Dysfunction in Pulmonary Hypertension: Cause or Consequence?
por: Kurakula, Kondababu, et al.
Publicado: (2021) -
Vascular Inflammation and Endothelial Dysfunction in Experimental Hypertension
por: Savoia, Carmine, et al.
Publicado: (2011)